Zentek (NASDAQ:ZTEK) Releases Quarterly Earnings Results

Key Points

• Zentek (NASDAQ:ZTEK) reported a quarterly earnings per share of ($0.01) with a negative net margin of 1,186.72% and a negative return on equity of 58.87%.
• The company's stock fell 3.8% to $0.81, with trading volume higher than its average at 42,674 shares.
• Zentek focuses on the research and development of graphene and related nanomaterials, producing products such as antimicrobial coatings and surgical masks.

Zentek (NASDAQ:ZTEK - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.01) earnings per share for the quarter, Zacks reports. Zentek had a negative net margin of 1,186.72% and a negative return on equity of 58.87%.

Zentek Stock Down 3.8%

ZTEK traded down $0.03 during trading on Thursday, reaching $0.81. 42,674 shares of the company were exchanged, compared to its average volume of 29,936. The firm has a 50 day moving average of $1.08 and a 200 day moving average of $1.17. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.25 and a quick ratio of 1.00. Zentek has a 52 week low of $0.50 and a 52 week high of $1.84.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.